Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors

Journal of the National Cancer Institute

Volumn 90, Issue 19, 1998, Pages 1468-1473

  Souttou, Boussad ^a   Juhl, Hartmut ^b   Hackenbruck, Joannah ^a   Röckseisen, Marianne ^b   Klomp, Hans Jürgen ^b   Raulais, Daniel ^c   Vigny, Marc ^c   Wellstein, Anton ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF KIEL   (Germany)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; PLEIOTROPHIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA;

EID: 0032494487     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.19.1468     Document Type: Article

References (25)

1. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333:1757-63.
2. Meyer GE, Yu E, Siegal JA, Petteway JC, Blumenstein BA, Brawer MK. Serum basic fibroblast growth factor in men with and without prostate carcinoma. Cancer 1995;76:2304-11.
3. Sliutz G, Tempfer C, Obermair A, Dadak C, Kainz C. Serum evaluation of basic FGF in breast cancer patients. Anticancer Res 1995; 15:2675-7.
4. Sliutz G, Tempfer C, Obermair A, Reinthaller A, Gitsch G, Kainz C. Serum evaluation of basic fibroblast growth factor in cervical cancer patients. Cancer Lett 1995;94:227-31.
5. Duensing S, Grosse J, Atzpodien J. Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patients. Anticancer Res 1995;15:2331-3.
6. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 1994;86: 356-60.
7. Soutter AD, Nguyen M, Watanabe H, Folkman J. Basic fibroblast growth factor secreted by an animal tumor is detectable in urine. Cancer Res 1993;53:5297-9.
8. Wellstein A. Why monitor angiogenic factors in patients' urine? [editorial]. J Natl Cancer Inst 1994;86:328-9.
9. Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, Kodner CM, et al. Cloning and expression of a developmentally regulated protein that induces mitogenic and neunte outgrowth activity. Science 1990;250:1690-4.
10. Kadomatsu K, Tomomura M, Muramatsu T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 1988;151: 1312-8.
11. Schulte AM, Wellstein A. Pleiotrophin and related molecules. In: Bicknell R, Lewis CM, Ferrara N, editors. Tumour angiogenesis. New York: Oxford University Press, 1997; p. 273-89.
12. Fang W, Hartmann N, Chow DT, Riegel AT, Wellstein A. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. J Biol Chem 1992; 267:25889-97.
13. Delbe J, Vacherot F, Laaroubi K, Barritault D, Courty J. Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide. J Cell Physiol 1995;164: 47-54.
14. Courty J, Dauchel MC, Caruelle D, Perderiset M, Barritault D. Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin. Biochem Biophys Res Commun 1991; 180:145-51.
15. Laaroubi K, Delbe J, Vacherot F, Desgranges P, Tardieu M, Jaye M, et al. Mitogenic and in vitro angiogenic activity of human recombinant heparin affin regulatory peptide. Growth Factors 1994;10:89-98.
16. Kojima S, Inui T, Muramatsu H, Kimura T, Sakakibara S, Muramatsu T. Midkine is a heat and acid stable polypeptide capable of enhancing plasminogen activator activity and neurite outgrowth extension. Biochem Biophys Res Commun 1995;216:574-81.
17. Chauhan AK, Li YS, Deuel TF. Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proc Natl Acad Sci U S A 1993; 90:679-82.
18. Czubayko F, Riegel AT, Wellstein A. Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth. J Biol Chem 1994; 269:21358-63.
19. Czubayko F, Schulte AM, Berchem GJ, Wellstein A. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proc Natl Acad Sci U S A 1996;93:14753-8.
20. Schulte AM, Lai S, Kurtz A, Czubayko F, Riegel AT, Wellstein A. Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc Natl Acad Sci U S A 1996;93:14759-4.
21. Beau I, Cockshutt AM, Regnier F, Chany-Fournier F, Raulais D. Retinoic-acid induced heparin binding protein (RIHB) binds to embryonal chondrocytes and cartilage primarily via proteoglycans. Exp Cell Res 1995;218: 531-9.
22. McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB, et al. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res 1993;53:2168-77.
23. Bohlen P, Kovesdi I, HBNF and MK, members of a novel gene family of heparin-binding proteins with potential roles in embryogenesis and brain function. Prog Growth Factor Res 1991; 3:143-57.
24. Novotny WF, Maffi T, Mehta RL, Milner PG. Identification of novel heparin-releasable proteins, as well as the cytokines midkine and pleiotrophin, in human postheparin plasma. Arterioscler Thromb 1993;13:1798-805.
25. Wellstein A, Fang WJ, Khatri A, Lu Y, Swain SS, Dickson RB, et al. A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine. J Biol Chem 1992;267:2582-7.